Abstract
No public abstract is available from the verified source records.
João Paulo Telles, Birgit Koch
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Impact of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) on cancer treatment outcomes: An overview about well-established and recently emerging clinical data
10.1016/j.critrevonc.2017.11.005 · 2017
Pharmacokinetic-pharmacodynamic modeling to evaluate the relative impact of immune response and meropenem on bacterial killing in vivo
10.1128/aac.01788-25 · 2026
Management of febrile neutropaenia: ESMO Clinical Practice Guidelines
10.1093/annonc/mdw325 · 2016
Australian PICNICC and There is No Place Like Home study groups. Impact of time to antibiotics on clinical outcome in paediatric febrile neutropenia: a target trial emulation of 1685 episodes
2024
Cohort study of the impact of time to antibiotic administration on mortality in patients with febrile neutropenia
10.1128/aac.02561-14 · 2014
2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignancies
2025
Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation: recommendations from the 10th European Conference on Infections in Leukaemia
2025
Club de Reflexion sur les Infections en Onco-Hématologie. Pharmacodynamics and pharmacokinetics of antibacterial drugs in the management of febrile neutropenia
10.1016/s1473-3099(08)70228-7 · 2008
Prolonged vs short-term infusion of β-lactam antibiotics for the treatment of febrile neutropenia: A systematic review and meta-analysis
10.1016/j.jinf.2023.06.023 · 2023
Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients (BEATLE): a randomized, multicentre, open-label, superiority clinical trial
10.1016/j.cmi.2024.10.006 · 2025
BLING III Study Investigators. Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial
10.1001/jama.2024.9779 · 2024
Antibiotic management of febrile neutropenia: current developments and future directions
10.1179/joc.2010.22.1.5 · 2010
Management of fever in patients with cancer and treatment-induced neutropenia
10.1056/nejm199305063281808 · 1993
Epidemiology and source of infection in cancer patients with febrile neutropenia: an experience from a developing country
10.1186/s12879-023-08058-6 · 2023
Efficacy and safety of withholding antimicrobial treatment in children with cancer, fever and neutropenia, with a demonstrated viral respiratory infection: a randomized clinical trial
10.1016/j.cmi.2016.11.001 · 2017
Efficacy and safety of withholding antimicrobial therapy in children with cancer, fever, and neutropenia, with a demonstrated viral respiratory infection: a randomized clinical trial
10.1016/j.cmi.2024.04.007 · 2024
Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation: recommendations from the 10th European Conference on Infections in Leukaemia
2025
Microbiological characterization of bacteremia in patients with chemotherapy-induced febrile neutropenia: systematic review and meta-analysis
2025
10.3390/antibiotics10121485
10.3390/antibiotics10121485
Penetration of Antibiotics into Subcutaneous and Intramuscular Interstitial Fluid: A Meta-Analysis of Microdialysis Studies in Adults
10.1007/s40262-024-01394-z · 2024
In Vivo Microdialysis To Determine Subcutaneous Interstitial Fluid Penetration and Pharmacokinetics of Fluconazole in Intensive Care Unit Patients with Sepsis
10.1128/aac.02461-15 · 2015
The importance of understanding the infectious microenvironment
10.1016/s1473-3099(21)00122-5 · 2022
Infusional β-lactam antibiotics in febrile neutropenia: has the time come?
10.1097/qco.0b013e32835915c2 · 2012
Population pharmacokinetics and optimized dosing of piperacillin-tazobactam in hematological patients with febrile neutropenia
10.1128/aac.01253-25 · 2026
Mechanism-Based Disease Progression Model Describing Host-Pathogen Interactions During the Pathogenesis of Acinetobacter baumannii Pneumonia
10.1002/psp4.12312 · 2018
Model-based assessment of neutrophil-mediated phagocytosis and digestion of bacteria across in vitro and in vivo studies
10.1002/psp4.13046 · 2023
Comparative In Vivo Efficacies of Tedizolid in Neutropenic versus Immunocompetent Murine Streptococcus pneumoniae Lung Infection Models
10.1128/aac.01957-16 · 2016
Impact of granulocytes on the antimicrobial effect of tedizolid in a mouse thigh infection model
10.1128/aac.00502-11 · 2011
Impact of attaining aggressive vs. conservative PK/PD target on the clinical efficacy of beta-lactams for the treatment of Gram-negative infections in the critically ill patients: a systematic review and meta-analysis
10.1186/s13054-024-04911-5 · 2024
No additional external references are available.